Innocan Pharma announced the successful completion of a large-scale production of exosomes. Innocan’s CBD Loaded Exosome (CLX) Therapy project led by Prof. Offen demonstrates the capability of having reliable large-scale production of exosomes and is an important milestone in the ...
Read More »Innocan Pharma collaborates with Tel Aviv University to develop a new revolutionary approach to treat the COVID-19 coronavirus with exosomes-loaded CBD
InnoCan Pharma announced that its wholly-owned subsidiary, InnoCan Pharma Ltd. of Herzliya Israel, has entered into a sponsored research agreement with Ramot at Tel Aviv University to collaborate with Tel Aviv university to develop a novel, revolutionary...
Read More »Stem Cell Medicine Licenses Exosome Technology for Treating Autism From Ramot at Tel Aviv University
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment of Multiple...
Read More »Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors
Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by three core symptoms that include social interaction deficits, cognitive inflexibility, and communication disorders...
Read More »Morphological and molecular features of oral fluid-derived exosomes
Oral cancer (OC) patients are at high risk to develop recurrent disease or secondary primary cancers with no available biomarkers to detect these events until a visible lesion is readily present and diagnosed by biopsy. Exosomes secreted by cancer cells ...
Read More »The “Cyberwar” Against Cancer Gets a Boost from Intelligent Nanocarriers
TAU researcher advances novel strategy to fight cancer by shoring up the immune system Two years ago, Prof. Eshel Ben-Jacob of Tel Aviv University‘s School of Physics and Astronomy and Rice University’s Center for Theoretical Biological Physics made the startling ...
Read More »